Cosmo Bio Co Stock

Cosmo Bio Co EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Cosmo Bio Co (3386.T) as of Jul 22, 2026 is 22.59. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 24.37 — a change of -7.29% (lower).

EV/EBIT

22.59

YoY

-7.29%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Cosmo Bio Co is 2026 22.59 . EV/EBIT (Enterprise Value to EBIT) of Cosmo Bio Co was 2025 24.37 . It decreases by -7.29% lower compared to the previous year.

The Cosmo Bio Co EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2018
15.89 base
Jan 1, 2019
15.34 base
Jan 1, 2020
9.66 base
Jan 1, 2021
6.44 base
Jan 1, 2022
7.19 base
Jan 1, 2023
11.04 base
Jan 1, 2024
19.79 base
Jan 1, 2025
21.62 base
YEARPRICE-TO-EBIT
2025 21.62
2024 19.79
2023 11.04
2022 7.19
2021 6.44
2020 9.66
2019 15.34
2018 15.89
2017 34.43
2016 14.47
2015 31.80
2014 56.70
2013 52.21
2012 8.79
2011 3.88
2010 5.22
2009 7.04
2008 6.06
2007 8.20
2006 8.23
Access this data via the Eulerpool API
Get Free API Key

Cosmo Bio Co Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Cosmo Bio Co's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Cosmo Bio Co's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Cosmo Bio Co's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Cosmo Bio Co grows earnings faster than its peers.

Cosmo Bio Co Stock analysis

What does Cosmo Bio Co do? Cosmo Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cosmo Bio Co stock

EV/EBIT (Enterprise Value to EBIT) of Cosmo Bio Co is 22.59 in 2026.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Cosmo Bio Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Cosmo Bio Co